1. Home
  2. Research
  3. ASX:WNX
ASX:WNX - Wellnex Life Limited Research

Revised Financial Projections and Valuation Outlook

WNX ASX Small Cap Research
Company Overview

Wellnex Life Ltd, an Australian company, develops, licenses, and markets healthcare products such as Wakey Wakey, Nighty Night, Pharmacy Own, The Iron Company, Mr Bright, and Pain Away. It has licensing agreements with Haleon and Arrotex. Through a joint venture with OneLife Botanical and Chemist Warehouse, it offers SAS-B medicinal cannabis under the Wellness Life brand. Wellnex Life also owns TGA registration for liquid soft gel analgesics, supplying them to pharmaceutical brands in Australia and internationally. Its products are distributed through pharmacy wholesale, grocery retailers, and supermarkets in Australia.

Release Date (6 months ago)
  •   May 17th, 2024
  • 0.021
All WNX Reports
Report Includes
  • Recent events
  • Investment highlights
  • Analyst's view
  • Consensus targets
  • More...
Analyst
SmallCapInsider
Research
Download Report

This desk note serves as an update to our previous report on Wellnex following significant revisions to their FY24 financial projections. The updated forecasts reflect material changes to our initial analysis, primarily due to operational headwinds.